6955 — Shandong Boan Biotechnology Co Balance Sheet
0.000.00%
- HK$6.80bn
- HK$7.33bn
- CNY726.32m
Annual balance sheet for Shandong Boan Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3.63 | 614 | 233 | 202 | 199 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 30.9 | 126 | 227 | 293 | 515 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 92.1 | 940 | 847 | 713 | 956 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 491 | 601 | 624 | 660 | 652 |
Net Intangible Assets | |||||
Total Assets | 908 | 2,107 | 2,203 | 2,323 | 2,851 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 396 | 260 | 472 | 653 | 649 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 426 | 555 | 784 | 1,004 | 1,207 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 482 | 1,552 | 1,418 | 1,320 | 1,644 |
Total Liabilities & Shareholders' Equity | 908 | 2,107 | 2,203 | 2,323 | 2,851 |
Total Common Shares Outstanding |